FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313650517> ?p ?o ?g. }

• W4313650517 endingPage "108337" @default.
• W4313650517 startingPage "108337" @default.
• W4313650517 abstract "The second messenger cyclic guanosine monophosphate (cGMP) is an important regulator of human (patho-)physiology and has emerged as an attractive drug target. Currently, cGMP-elevating drugs are mainly used to treat cardiovascular diseases, but there is also increasing interest in exploring their potential for cancer prevention and therapy. In this review article, we summarise recent findings in cancer-related cGMP research, with a focus on melanoma, breast cancer, colorectal cancer, prostate cancer, glioma, and ovarian cancer. These studies indicate tremendous heterogeneity of cGMP signalling in tumour tissue. It appears that different tumour and stroma cells, and perhaps different sexes, express different cGMP generators, effectors, and degraders. Therefore, the same cGMP-elevating drug can lead to different outcomes in different tumour settings, ranging from inhibition to promotion of tumourigenesis or therapy resistance. These findings, together with recent evidence that increased cGMP signalling is associated with worse prognosis in several human cancers, challenge the traditional view that cGMP elevation generally has an anti-cancer effect. As cGMP pathways appear to be more stable in the stroma than in tumour cells, we suggest that cGMP-modulating drugs should preferentially target the tumour microenvironment. Indeed, there is evidence that phosphodiesterase 5 inhibitors like sildenafil enhance anti-tumour immunity by acting on immune cells. Moreover, many in vivo results obtained with cGMP-modulating drugs could be explained by effects on the tumour vasculature rather than on the tumour cells themselves. We therefore propose a model that incorporates the NO/cGMP signalling pathway in tumour vessels as a key target for cancer therapy. Deciphering the multifaceted roles of cGMP in cancer is not only a challenge for basic research, but also provides a chance to predict potential adverse effects of cGMP-modulating drugs in cancer patients and to develop novel anti-tumour therapies by precision targeting of the relevant cells and molecular pathways." @default.
• W4313650517 created "2023-01-07" @default.
• W4313650517 creator A5027100530 @default.
• W4313650517 creator A5067008606 @default.
• W4313650517 creator A5072616293 @default.
• W4313650517 creator A5079582665 @default.
• W4313650517 date "2023-02-01" @default.
• W4313650517 modified "2023-10-01" @default.
• W4313650517 title "Heterogeneity of cGMP signalling in tumour cells and the tumour microenvironment: Challenges and chances for cancer pharmacology and therapeutics" @default.
• W4313650517 cites W1500820977 @default.
• W4313650517 cites W1603230122 @default.
• W4313650517 cites W1836315310 @default.
• W4313650517 cites W1967695112 @default.
• W4313650517 cites W1977179270 @default.
• W4313650517 cites W1978139448 @default.
• W4313650517 cites W1989526884 @default.
• W4313650517 cites W1990826929 @default.
• W4313650517 cites W1997023449 @default.
• W4313650517 cites W1997459488 @default.
• W4313650517 cites W2000078674 @default.
• W4313650517 cites W2004150448 @default.
• W4313650517 cites W2006202974 @default.
• W4313650517 cites W2009334802 @default.
• W4313650517 cites W2014896540 @default.
• W4313650517 cites W2016571009 @default.
• W4313650517 cites W2020252252 @default.
• W4313650517 cites W2021070226 @default.
• W4313650517 cites W2026682712 @default.
• W4313650517 cites W2029124536 @default.
• W4313650517 cites W2030435645 @default.
• W4313650517 cites W2034269086 @default.
• W4313650517 cites W2034649274 @default.
• W4313650517 cites W2035252444 @default.
• W4313650517 cites W2039108002 @default.
• W4313650517 cites W2040663949 @default.
• W4313650517 cites W2042288688 @default.
• W4313650517 cites W2048942694 @default.
• W4313650517 cites W2051703091 @default.
• W4313650517 cites W2054071295 @default.
• W4313650517 cites W2064497915 @default.
• W4313650517 cites W2065731223 @default.
• W4313650517 cites W2067541859 @default.
• W4313650517 cites W2068696687 @default.
• W4313650517 cites W2070251370 @default.
• W4313650517 cites W2070737114 @default.
• W4313650517 cites W2070897791 @default.
• W4313650517 cites W2072880806 @default.
• W4313650517 cites W2075637623 @default.
• W4313650517 cites W2076055196 @default.
• W4313650517 cites W2084642119 @default.
• W4313650517 cites W2086797785 @default.
• W4313650517 cites W2089336390 @default.
• W4313650517 cites W2090458427 @default.
• W4313650517 cites W2093504658 @default.
• W4313650517 cites W2098789742 @default.
• W4313650517 cites W2104454299 @default.
• W4313650517 cites W2106742989 @default.
• W4313650517 cites W2108489104 @default.
• W4313650517 cites W2111168553 @default.
• W4313650517 cites W2115993532 @default.
• W4313650517 cites W2118462346 @default.
• W4313650517 cites W2120539661 @default.
• W4313650517 cites W2123105952 @default.
• W4313650517 cites W2126020984 @default.
• W4313650517 cites W2128985829 @default.
• W4313650517 cites W2131009163 @default.
• W4313650517 cites W2131783235 @default.
• W4313650517 cites W2134127402 @default.
• W4313650517 cites W2134528462 @default.
• W4313650517 cites W2137816700 @default.
• W4313650517 cites W2141240574 @default.
• W4313650517 cites W2141414987 @default.
• W4313650517 cites W2141865234 @default.
• W4313650517 cites W2143580838 @default.
• W4313650517 cites W2147009857 @default.
• W4313650517 cites W2157520113 @default.
• W4313650517 cites W2162337307 @default.
• W4313650517 cites W2164314627 @default.
• W4313650517 cites W2168631000 @default.
• W4313650517 cites W2171784121 @default.
• W4313650517 cites W2208114687 @default.
• W4313650517 cites W2222836159 @default.
• W4313650517 cites W2293355601 @default.
• W4313650517 cites W2303679694 @default.
• W4313650517 cites W2311521906 @default.
• W4313650517 cites W2319350696 @default.
• W4313650517 cites W2339607607 @default.
• W4313650517 cites W2346214014 @default.
• W4313650517 cites W2513025522 @default.
• W4313650517 cites W2530564461 @default.
• W4313650517 cites W2555264388 @default.
• W4313650517 cites W2557774417 @default.
• W4313650517 cites W2607034898 @default.
• W4313650517 cites W2612504410 @default.
• W4313650517 cites W2615193500 @default.
• W4313650517 cites W2615680972 @default.
• W4313650517 cites W2615885638 @default.
• W4313650517 cites W2750794111 @default.

• next